(1)
Hansen Ree, A.; Mælandsmo, G. M.; Flatmark, K.; Russnes, H. G.; Gómez Castañeda, M.; Aas, E. Cost-Effectiveness of Molecularly Matched off-Label Therapies for End-Stage Cancer – the MetAction Precision Medicine Study. AO 2022, 61, 955-962.